527 related articles for article (PubMed ID: 31539192)
21. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
22. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
23. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
[TBL] [Abstract][Full Text] [Related]
24. L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.
Xu W; Kong Y; Zhang T; Gong Z; Xiao W
J Sci Food Agric; 2023 Feb; 103(3):1283-1293. PubMed ID: 36087337
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
[TBL] [Abstract][Full Text] [Related]
26. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
Sun J; Fan J; Li T; Yan X; Jiang Y
J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
[TBL] [Abstract][Full Text] [Related]
27. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
[TBL] [Abstract][Full Text] [Related]
28. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
Lan T; Rao A; Haywood J; Kock ND; Dawson PA
J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
[TBL] [Abstract][Full Text] [Related]
29. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
[TBL] [Abstract][Full Text] [Related]
30. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism.
Tawulie D; Jin L; Shang X; Li Y; Sun L; Xie H; Zhao J; Liao J; Zhu Z; Cui H; Wen W
Phytomedicine; 2023 May; 113():154733. PubMed ID: 36870307
[TBL] [Abstract][Full Text] [Related]
31. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.
Gonzalez FJ; Jiang C; Patterson AD
Gastroenterology; 2016 Nov; 151(5):845-859. PubMed ID: 27639801
[TBL] [Abstract][Full Text] [Related]
32. Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling.
Xiao Y; Zhou K; Lu Y; Yan W; Cai W; Wang Y
Exp Mol Med; 2018 Nov; 50(12):1-14. PubMed ID: 30504803
[TBL] [Abstract][Full Text] [Related]
33. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
34. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.
Qiu Y; Yu J; Li Y; Yang F; Yu H; Xue M; Zhang F; Jiang X; Ji X; Bao Z
Ann Med; 2021 Dec; 53(1):508-522. PubMed ID: 33783283
[No Abstract] [Full Text] [Related]
35. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
[TBL] [Abstract][Full Text] [Related]
36. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
[TBL] [Abstract][Full Text] [Related]
37. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
[TBL] [Abstract][Full Text] [Related]
38. Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR-FGF15 signaling pathway.
Zhou YF; Nie J; Shi C; Zheng WW; Ning K; Kang J; Sun JX; Cong X; Xie Q; Xiang H
Int J Biol Macromol; 2023 Sep; 248():125725. PubMed ID: 37419267
[TBL] [Abstract][Full Text] [Related]
39. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.
Li F; Jiang C; Krausz KW; Li Y; Albert I; Hao H; Fabre KM; Mitchell JB; Patterson AD; Gonzalez FJ
Nat Commun; 2013; 4():2384. PubMed ID: 24064762
[TBL] [Abstract][Full Text] [Related]
40. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]